About MBCCOP, Virginia Commonwealth University
Virginia Commonwealth University is a public research university in Richmond, Virginia. VCU was founded in 1838 as the medical department of Hampden–Sydney College, becoming the Medical College of Virginia in 1854.
Clinical Trials at MBCCOP, Virginia Commonwealth University
During the past decade, MBCCOP, Virginia Commonwealth University conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "MBCCOP, Virginia Commonwealth University"
#1 collaborator was "Genentech, Inc." with 3 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at MBCCOP, Virginia Commonwealth University
According to Clinical.Site data, the most researched conditions in "MBCCOP, Virginia Commonwealth University" are
"Breast Cancer" (3 trials), "HIV Infections" (2 trials), "Cardiovascular Diseases" (1 trials), "Colorectal Cancer" (1 trials) and "Hepatitis C" (1 trials). Many other conditions were trialed in "MBCCOP, Virginia Commonwealth University" in a lesser frequency.
Clinical Trials Intervention Types at MBCCOP, Virginia Commonwealth University
Most popular intervention types in "MBCCOP, Virginia Commonwealth University" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (2 trials), "Cyclophosphamide" (2 trials), "Docetaxel" (2 trials), "Epirubicin" (2 trials) and "Trastuzumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at MBCCOP, Virginia Commonwealth University
The vast majority of trials in "MBCCOP, Virginia Commonwealth University" are
4 trials for "Female" genders and 3 trials for "All" genders.
Clinical Trials Status at MBCCOP, Virginia Commonwealth University
Currently, there are NaN active trials in "MBCCOP, Virginia Commonwealth University".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in MBCCOP, Virginia Commonwealth University,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in MBCCOP, Virginia Commonwealth University, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".